Speaker Profile

Ph.D., CEO, Resilient Biotics

Chris currently serves as CEO of Resilient Biotics, a company he co-founded and launched within the Illumina Accelerator program. Resilient Biotics utilizes metagenomic-based network analyses and machine learning tools to explore microbiome systems and uncover novel therapeutic opportunities to combat respiratory infectious diseases. With an advanced genomic platform that integrates host and microbial genomic data, Resilient is developing the next class of non-antibiotic therapeutics. Chris has a background in microbial systems analyses and has spent his career as a scientific leader investigating complex microbiome communities. Prior to Resilient, Chris led projects focused on microbiome product discovery for plant and animal agricultural applications at DuPont Pioneer, and Taxon Biosciences (acquired by DuPont). Chris received his Ph.D. in microbiology at the University of California, Berkeley, and was awarded a postdoctoral fellowship grant to study human microbiome communities at the University of California, San Francisco.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.